HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up.

AbstractOBJECTIVE:
We conducted an 8-wk controlled study with topical 0.075% capsaicin in subjects with chronic severe painful diabetic neuropathy who were unresponsive or intolerant to conventional therapy. Capsaicin is an alkaloid found in capsicum peppers and produces desensitization to noxious thermal, chemical, and mechanical stimuli when applied topically.
RESEARCH DESIGN AND METHODS:
In 22 randomly assigned subjects, either capsaicin or vehicle cream was applied to painful areas 4 times/day. Pain measurements were recorded at baseline and at 2-wk intervals for 8 wk.
RESULTS:
Capsaicin treatment was more beneficial than vehicle treatment in the overall clinical improvement of pain status, as measured by physician's global evaluation (P = 0.038) and by a categorical pain severity scale (P = 0.057). Decrease in mean pain intensity by a visual analogue scale was 16% in capsaicin-treated and 4.1% in vehicle-treated subjects. Mean pain relief on visual analogue scale was 44.6 and 23.2%, respectively. In a follow-up open-label study, approximately 50% of subjects reported improved pain control or were cured, and 25% each were unchanged or worse. A burning sensation at the application site was noted by some subjects but both its magnitude and duration decreased with time.
CONCLUSIONS:
Results from this preliminary study suggest that topical 0.075% capsaicin may be of value in subjects with diabetic neuropathy and intractable pain.
AuthorsR Tandan, G A Lewis, P B Krusinski, G B Badger, T J Fries
JournalDiabetes care (Diabetes Care) Vol. 15 Issue 1 Pg. 8-14 (Jan 1992) ISSN: 0149-5992 [Print] United States
PMID1737545 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Glycated Hemoglobin A
  • Capsaicin
Topics
  • Administration, Topical
  • Capsaicin (administration & dosage, adverse effects, therapeutic use)
  • Diabetic Neuropathies (drug therapy, physiopathology)
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Glycated Hemoglobin (analysis)
  • Humans
  • Male
  • Middle Aged
  • Pain, Intractable (drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: